Lead sponsor
RenJi Hospital
5 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
5
Trials led
1
Active
1,127
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 3
1
Phase 4
2
Not applicable
2
Trials by status
Not yet recruiting
1
Completed
1
Unknown
3
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes MellitusBMI ≥24not applicableUnknown300
Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney DiseaseBMI ≥25not applicableUnknown48